Delivery of pharmaceutical products for treatment of oncological and hematological diseases and blood coagulation factors for the needs of UMBAL Dr. Georgi Stranski EAD - Pleven
Oryginalny tytuł ogłoszenia
Bulgaria – Pharmaceutical products – „Доставка на лекарствени продукти за лечение на онкологични и хематологични заболявания и фактори за кръвосъсирване за нуждите на УМБАЛ „Д-р Георги Странски” ЕАД - Плевен”
Ocena szansy
Skąd ta ocena?
Szansa
70 / 100
Złożoność
60 / 100
Czynniki ryzyka
Structured data indicates EU funding, but XML notice states 'no-eu-funds'. This could affect contract terms or budget.
Requires specific wholesale and possibly manufacturer authorizations for each product, which may narrow the field of el...
Restricted procedure — pre-qualification required
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Przegląd
Strong opportunityKluczowe fakty
- BGN 324.7M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration 36 MONTH
- Delivery of pharmaceutical products for oncology and hematology
- Delivery of blood coagulation factors
Pokaż pełne podsumowanie
This is a restricted procedure for a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products for oncological and hematological diseases and blood coagulation factors to the University Hospital Dr. Georgi Stranski in Pleven, Bulgaria. The estimated value is 324,733,078.61 BGN, with a duration of 36 months. The deadline for submission is 2028-05-02. The award is based on lowest price.
Ryzyka
Structured data indicates EU funding, but XML notice states 'no-eu-funds'. This could affect contract terms or budget.
Requires specific wholesale and possibly manufacturer authorizations for each product, which may narrow the field of el...
Restricted procedure — pre-qualification required
Analiza może być niepełna
Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.
Kluczowe wymagania
Technical
- Must be a registered trader permitted to wholesale medicinal products
- Must hold a wholesale authorization for medicinal products from the Bulgarian Drug Agency (IAL) or equivalent from another EU member state
- If manufacturer, must hold production authorization or authorization from the product manufacturer
Wymagania mogą być niepełne.
Kryteria udzielenia
Lot 1
Zamawiający
Lokalizacja
гр. Плевен, BGR
Profil zamawiającego
Identyfikator
114532352
Działalność
Health
Części (1)
LOT-0001
Delivery of pharmaceutical products for treatment of oncological and hematological diseases and blood coagulation factors for the needs of UMBAL Dr. Georgi Stranski EAD - Pleven
Supply of oncological and hematological medicines and blood clotting factors as per technical specifications. The lot is a DPS with continuous competition.
BGN 324.7M
Szacowana wartość
Lokalizacja
Czas trwania
Kategoria
Kryteria udzielenia
Termin
Szczegóły kryteriów
На първо място се класира участникът, предложил най-ниска цена. Останалите оферти заемат места в класирането по низходящ ред
Uwaga do wartości
Pokaż oryginalne dane TED
Oryginalny tytuł części
„Доставка на лекарствени продукти за лечение на онкологични и хематологични заболявания и фактори за кръвосъсирване за нуждите на УМБАЛ „Д-р Георги Странски” ЕАД - Плевен”
Oryginalny opis TED
Процедура по реда на Закона за обществените поръчки за лекарствени продукти за лечение на онкологични и хематологични и фактори за кръвосъсирване за нуждите на „УМБАЛ Д-р Георги Странски” ЕАД – Плевен,, по смисъла на Закона за лекарствените продукти в хуманната медицина , съгласно техническата спецификация и условията на настоящата документация.
Szczegóły zamówienia
- Data publikacji
- 02 Apr 2025
- Języki
- Bulgarian
Metadane referencyjne
- Podstawa prawna
- 32014L0024
Identyfikatory referencyjne
- ID przetargu
- 216830-2025
Dokumenty (1)
Podobne przetargi
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Ocena szansy
Skąd ta ocena?
Szansa
70 / 100
Złożoność
60 / 100
Czynniki ryzyka
Structured data indicates EU funding, but XML notice states 'no-eu-funds'. This could affect contract terms or budget.
Requires specific wholesale and possibly manufacturer authorizations for each product, which may narrow the field of el...
Restricted procedure — pre-qualification required
Głęboka analiza portfolio
Wykorzystuje:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications